Locust Walk Acquisition registered an additional 2.3 million units to upsize its IPO to $153 million, an 18 percent increase. The new SPAC initially filed to raise $130 million.
The SPAC is focusing on the healthcare sector or healthcare-related industries in the United States and Europe, especially companies in the life sciences sector.
Locust Walk units begin trading today on the Nasdaq under LWACU. Read more.